These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33635913)

  • 21. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.
    Dietz VJ; Stevenson J; Zell ER; Cochi S; Hadler S; Eddins D
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):943-9. PubMed ID: 8075738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of WhatsApp group messaging in the coordination of measles supplemental immunization activity in Cross Rivers State, Nigeria, 2018.
    Masresha B; Nwankwo O; Bawa S; Igbu T; Oteri J; Tafida H; Braka F
    Pan Afr Med J; 2020; 35(Suppl 1):6. PubMed ID: 32373257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan (2017-18): a randomized controlled trial.
    Siddiqi DA; Ali RF; Munir M; Shah MT; Khan AJ; Chandir S
    BMC Public Health; 2020 Jul; 20(1):1086. PubMed ID: 32652969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Momoh J; Oteri AJ; Mogekwu F; Onwu N; Dieng B; Bawa S; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C12-C20. PubMed ID: 33714654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa.
    Grout L; Conan N; Juan Giner A; Hurtado N; Fermon F; N'Goran A; Grellety E; Minetti A; Porten K; Grais RF
    BMC Public Health; 2014 Feb; 14():193. PubMed ID: 24559281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    Oyo-Ita A; Bosch-Capblanch X; Ross A; Oku A; Esu E; Ameh S; Oduwole O; Arikpo D; Meremikwu M
    PLoS One; 2021; 16(4):e0248236. PubMed ID: 33861742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan: protocol for a randomized controlled trial.
    Siddiqi DA; Munir M; Shah MT; Khan AJ; Chandir S
    BMC Public Health; 2019 Oct; 19(1):1421. PubMed ID: 31666039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.
    Adetifa IMO; Karia B; Mutuku A; Bwanaali T; Makumi A; Wafula J; Chome M; Mwatsuma P; Bauni E; Hammitt LL; Mataza C; Tabu C; Kamau T; Williams TN; Scott JAG
    Vaccine; 2018 Dec; 36(52):7965-7974. PubMed ID: 30416017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Terna Richard M; Taiwo L; Jean Baptiste AE; Bawa S; Dieng B; Wiwa O; Lambo K; Braka F; Shuaib F; Oteri J
    Vaccine; 2021 Nov; 39 Suppl 3():C21-C28. PubMed ID: 34247903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles vaccination coverage, determinants of delayed vaccination and reasons for non-vaccination among children aged 24-35 months in Zhejiang province, China.
    Hu Y; Wang Y; Chen Y; Liang H; Chen Z
    BMC Public Health; 2018 Nov; 18(1):1298. PubMed ID: 30482185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of missed opportunities for vaccination in Kenyan health facilities, 2016.
    Li AJ; Tabu C; Shendale S; Sergon K; Okoth PO; Mugoya IK; Machekanyanga Z; Onuekwusi IU; Sanderson C; Ogbuanu IU
    PLoS One; 2020; 15(8):e0237913. PubMed ID: 32817630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a mass measles campaign in central Afghanistan, December 2001 to May 2002.
    Dadgar N; Ansari A; Naleo T; Brennan M; Salama P; Sadozai N; Golaz A; Lievano F; Jafari H; Mubarak M; Hoekstra E; Paganini A; Feroz F
    J Infect Dis; 2003 May; 187 Suppl 1():S186-90. PubMed ID: 12721912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass measles vaccination in urban Burkina Faso, 1998.
    Zuber PL; Conombo KS; Traoré AD; Millogo JD; Ouattara A; Ouédraogo IB; Valian A
    Bull World Health Organ; 2001; 79(4):296-300. PubMed ID: 11357207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inequalities in measles immunization coverage in Ethiopia: a cross-sectional analysis of demographic and health surveys 2000-2016.
    Shibre G; Zegeye B; Idriss-Wheeler D; Yaya S
    BMC Infect Dis; 2020 Jul; 20(1):481. PubMed ID: 32635891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine Immunization Coverage and Immunization Card Retention in Pakistan: Results From a Cross-sectional National Survey.
    Hussain I; Khan A; Rhoda DA; Ahmed I; Umer M; Ansari U; Shah MA; Yunus S; Brustrom J; Oelrichs R; Soofi SB; Bhutta ZA
    Pediatr Infect Dis J; 2023 Mar; 42(3):260-270. PubMed ID: 36728580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.